ArticleMMWR. Morbidity and mortality weekly report2019
Diabetes Prevalence and Incidence Among Medicare Beneficiaries - United States, 2001-2015.
Article in MMWR. Morbidity and mortality weekly report, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 49 citations in OpenAlex.
- Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial.The Journal of clinical endocrinology and metabolism · 2021Trial
- Rural-urban disparities in diabetes quality of care with accountable care organization participation.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2026Article
- Policy Impediments to Tuberculosis Elimination: Consequences of an Absent Medicare National Coverage Determination for Tuberculosis Prevention.Journal of immigrant and minority health · 2025Article
- Utilization of Diabetes Self-Management Education and Support Among Medicare Beneficiaries Newly Diagnosed With Diabetes in Arkansas, 12 Months Postdiagnosis (2015-2018).The science of diabetes self-management and care · 2024Article
- Which Social Variables Predict Diabetes Onset? Robust Findings in Two National Surveys.The Gerontologist · 2024Article
- Lifetime Medical Spending Attributed to Incident Type 2 Diabetes in Medicare Beneficiaries: A Longitudinal Study Using 1999-2019 National Medicare Claims.Diabetes care · 2024Article
- Analysis of eligibility criteria in Alzheimer's and related dementias clinical trials.Scientific reports · 2024Article
- Receipt of Diabetes Specialty Care and Management Services by Older Adults With Diabetes in the U.S., 2015-2019: An Analysis of Medicare Fee-for-Service Claims.Diabetes care · 2024Article
- Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes.Diabetes care · 2024Article
- Social determinants of health and diabetes: using a nationally representative sample to determine which social determinant of health model best predicts diabetes risk.Clinical diabetes and endocrinology · 2024Article
- Age at diagnosis of diabetes, obesity, and the risk of dementia among adult patients with type 2 diabetes.PloS one · 2024Article
- Optimal Look-Back Period to Identify True Incident Cases of Diabetes in Medical Insurance Data in the Chinese Population: Retrospective Analysis Study.JMIR public health and surveillance · 2023Article
- Understanding the Association of Older Adult Fall Risk Factors by Age and Sex Through Factor Analysis.Journal of applied gerontology : the official journal of the Southern Gerontological Society · 2023Article
- Medical Costs Associated With Diabetes Complications in Medicare Beneficiaries Aged 65 Years or Older With Type 1 Diabetes.Diabetes care · 2023Article
- Medical Costs Associated With Diabetes Complications in Medicare Beneficiaries Aged 65 Years or Older With Type 2 Diabetes.Diabetes care · 2022Article
- Consequences of forgoing prescription drug subsidies among low-income Medicare beneficiaries with diabetes.Health services research · 2022Article
- Underlying mechanisms of change in cancer prevalence in older U.S. adults: contributions of incidence, survival, and ascertainment at early stages.Cancer causes & control : CCC · 2022Article
- Update on the management of diabetes in long-term care facilities.BMJ open diabetes research & care · 2022Review
- Proportions and trends of adult hospitalizations with Diabetes, United States, 2000-2018.Diabetes research and clinical practice · 2022Article
- Trends in Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Medicare Part B Fee-for-Service Beneficiaries.JAMA ophthalmology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes affects approximately 12% of the U.S. adult population and approximately 25% of adults aged ≥65 years. From 2009 to 2017, there was no significant change in diabetes prevalence overall or among persons aged 65-79 years (1). However, these estimates were based on survey data with <5,000 older adults. Medicare administrative data sets, which contain claims for millions of older adults, afford an opportunity to explore both trends over time and heterogeneity within an older population. Previous studies have shown that claims data can be used to identify persons with diagnosed diabetes (2). This study estimated annual prevalence and incidence of diabetes during 2001-2015 using Medicare claims data for beneficiaries aged ≥68 years and found that prevalence plateaued after 2012 and incidence decreased after 2006. In 2015 (the most recent year estimated) prevalence was 31.6%, and incidence was 3.0%. Medicare claims can serve as an important source of data for diabetes surveillance for the older population, which can inform prevention and treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.